Resolutions approved by the 30 April 2025 General Meeting of shareholders of Rokiskio suris AB (hereinafter – the Company): 1. Auditor’s findings regarding the consolidated financial reports and management report.The report is heard. (No decision taken on this item). 2. The Audit Committee report.The conclusion of the Audit Committee is endorsed (attached). 3. The Company’s consolidated management report for the year 2024.The consolidated management report of the Company for 2024, prepared by the Company, r ...

TRESU INVESTMENT HOLDING A/S ANNOUNCEMENT NO. 05.2025 30.04.2025 TRESU Investment Holding A/S – Annual Report 2024 The Board of Directors and the Executive Board have today considered and approved the Annual Report of Tresu Investment Holding A/S for the financial year 01.01.2024 – 31.12.2024. The Annual Report is presented in accordance with IFRS Accounting Standards as adopted by EU and additional requirements applying to Danish companies. We are pleased to invite you to the financial results call, which ...

AB “Ignitis grupė” (hereinafter – the Group) informs that on 30 April 2025 the National Energy Regulatory Council (hereinafter – NERC) passed a resolution “On the amendment of the National Energy Regulatory Council's Resolution No. O3-229 of 14 September 2012 ‘On the approval of the methodology for determining the electricity price and the price for reserve capacity and isolated system operation services’” (link in Lithuanian) (hereinafter – the Resolution), which adopted the new mechanism for distributing ...

SPARTANBURG, S.C.,, April 30, 2025 (GLOBE NEWSWIRE) -- Denny’s, (NASDAQ: DENN), America’s Diner, proudly celebrates the newest recipients of its prestigious Hungry for Education™ Scholarship Program, awarding $161,000 in scholarships to outstanding students from across the country who are driving change in their communities. For more than thirteen years, Denny’s has been committed to supporting multicultural communities through its Hungry for Education™ Scholarship Program. Understanding the critical role o ...

The net asset value of INVL Baltic Real Estate, as provided in the Articles of Association section XI 'Valuation of assets of the company and calculation of the net asset value’, amounted to EUR 25,388,886 or EUR 3.1920 per share on 31 March 2025. The person authorized to provide additional information: Real Estate Fund Manager of Management Company Vytautas Bakšinskas E-mail vytautas.baksinskas@invl.com ...

For 3 months of 2025, the unaudited consolidated net profit of the INVL Baltic Real Estate (hereinafter – the Company) group was EUR 0.14 million, revenue was EUR 0.93 million (for 3 months of 2024 consolidated net profit was EUR 0.22 million, revenue was EUR 1.05 million). The unaudited net profit of Company itself amounted to EUR 0.14 million for 3 months of 2025 and EUR 0.22 million for 3 months of 2024. The decrease in the profit and revenue was mainly due to the sale of part of the Dommo Biznesa Parks ...

30 April 2025 – Prosafe SE today published the Annual report, Transparency Act Statement and Remuneration report for 2024. The Annual report includes the 2024 annual accounts, corporate governance report and sustainability report. On 31 January 2025, Prosafe reported preliminary and unaudited results for the fourth quarter and full year 2024. Today’s audited accounts include adjustments to EBITDA and net loss compared to the end-January preliminary figures following the sale of the Safe Concordia completed ...

Group 1 - BioSyent Inc. will present at the 2025 Bloom Burton & Co. Healthcare Investor Conference in Toronto on May 5 and 6, 2025 [1] - Mr. René Goehrum, President and CEO, will provide an overview of the company's business and corporate activities on May 5 at 11:30am EDT [1] - One-on-one meetings with Mr. Goehrum can be scheduled by registered attendees through the conference portal [2] Group 2 - BioSyent is a profitable growth-oriented specialty pharmaceutical company focused on in-licensing or acquiring innovative healthcare products [3] - The company supports healthcare professionals by marketing its products through community, specialty, and international business units [3] - As of the press release date, BioSyent has 11,254,638 common shares outstanding [4]

Core Insights - The report presents the financial statements of WisdomTree Multi Asset Issuer Public Limited Company for the year ended December 31, 2024, indicating the company's performance and financial health [1]. Financial Performance - The financial statements include detailed information on the company's revenue, expenses, and net income for the fiscal year, which are crucial for assessing the company's profitability and operational efficiency [1]. - The report highlights any significant changes in financial metrics compared to previous years, providing insights into growth trends and potential areas of concern [1]. Regulatory Compliance - The document serves as a regulatory filing, ensuring that the company adheres to the necessary financial reporting standards and transparency requirements set by relevant authorities [1]. - It includes disclosures that are essential for investors and stakeholders to understand the company's financial position and compliance status [1].

Core Insights - The Ordinary General Meeting of Amber Grid Shareholders approved the audited consolidated and separate financial statements and the consolidated annual report for the year 2024 [1] - The distribution of profits for AB Amber Grid for 2024 was also approved during the meeting [1] Financial Performance - Revenue for 2024 was EUR 74.6 million, a decrease from EUR 82.2 million in 2023, representing a decline of approximately 9.6% [3] - EBITDA for 2024 was EUR 26.5 million, slightly up from EUR 26.3 million in 2023, indicating a marginal increase of about 0.8% [3] - Net profit for 2024 was EUR 8.3 million, down from EUR 13.0 million in 2023, reflecting a decrease of approximately 36.2% [3]